You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三愛健康集團(01889.HK)收到聯交所復牌指引 繼續停牌
格隆匯 02-12 12:30

格隆匯2月12日丨三愛健康集團(01889.HK)公佈,於2020年2月7日,公司收到聯交所的函件,其載有以下有關公司股份恢復買賣的指引(“復牌指引”):“證明其遵守上市規則第13.24條。

倘公司的情況有變,聯交所可能修改或補充復牌指引。根據上市規則第6.01A條,倘公司的股份已連續18個月暫停買賣(於2021年7月23日屆滿),聯交所可將公司除牌。在適當情況下,聯交所有權根據上市規則第6.10條施加較短的特定補救期。

就復牌指引而言,公司將於其證券獲准恢復買賣前制定計劃,以糾正導致其暫停買賣的問題,並將全面遵守上市規則致令聯交所滿意。公司亦將聘請法律顧問及財務顧問以協助復牌行動,以及編制向聯交所提交的復牌計劃書。

集團將繼續主要從事(i)醫藥產品業務,包括醫藥產品的開發、製造、行銷和銷售,以及保健產品的銷售;(ii)提供融資租賃服務;(iii)其他一般貿易,包括醫藥產品以外商品的貿易;及(iv)提供基因檢測和分子診斷服務。

公司表示,董事會將採納若干措施以改善集團的業務能力,包括但不限於(i)優化產品線及改善行銷以提升市場佔有率;(ii)加強不同渠道的銷售及宣傳策略以提升市場滲透;及(iii)監察其行銷策略以迎合國內醫藥產品市場的取向及氛圍。

此外,公司股份繼續停牌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account